Yu Gu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 3
- Co-authors
- Wei Cang (8 shared papers)Scott Antonia (3 shared papers)Sarah B. Goldberg (3 shared papers)Joyson Karakunnel (3 shared papers)Rachel E. Sanborn (3 shared papers)Ani Sarkis Balmanoukian (3 shared papers)Naiyer A. Rizvi (3 shared papers)Keith E. Steele (3 shared papers)
- Journals
- Frontiers in Oncology (10 papers)International Journal of Gynecology & Obstetrics (2 papers)Annals of Oncology (2 papers)The Lancet Oncology (2 papers)Clinical Rehabilitation (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yu Gu
57 papers receiving 1.5k citations
Yu Gu's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 601
- Immunology 284
- Cancer Research 169
- Geochemistry and Petrology 67
- Obstetrics and Gynecology 70
Countries citing papers authored by Yu Gu
This map shows the geographic impact of Yu Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Gu more than expected).
Fields of papers citing papers by Yu Gu
This network shows the impact of papers produced by Yu Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Gu. The network helps show where Yu Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study Hit paper breakdown → | 2016 | 485 |
| 2 | Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression Hit paper breakdown → | 2022 | 241 |
| 3 | 2019 | 124 | |
| 4 | 2021 | 61 | |
| 5 | 1994 | 51 | |
| 6 | 2020 | 44 | |
| 7 | 2018 | 42 | |
| 8 | 2015 | 40 | |
| 9 | 2010 | 39 | |
| 10 | 2010 | 29 | |
| 11 | 2021 | 21 | |
| 12 | 2023 | 19 | |
| 13 | 2023 | 18 | |
| 14 | 2021 | 18 | |
| 15 | 2013 | 18 | |
| 16 | 2020 | 16 | |
| 17 | 2022 | 15 | |
| 18 | 2018 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2022 | 14 |
About Yu Gu
Yu Gu is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Statistical and Nonlinear Physics and Obstetrics and Gynecology, having authored 65 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Fusion and Plasma Physics Studies (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cold Fusion and Nuclear Reactions (5 papers), Cancer-related molecular mechanisms research (4 papers), Cervical Cancer and HPV Research (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (601 citations), Immunology (284 citations), Cancer Research (169 citations), Geochemistry and Petrology (67 citations) and Obstetrics and Gynecology (70 citations). Yu Gu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Wei Cang, Scott Antonia, Sarah B. Goldberg, Joyson Karakunnel, Rachel E. Sanborn, Ani Sarkis Balmanoukian, Naiyer A. Rizvi, Keith E. Steele, Rajesh Narwal and Lihua Chen. Their work appears in journals such as Frontiers in Oncology, International Journal of Gynecology & Obstetrics, Annals of Oncology, The Lancet Oncology and Clinical Rehabilitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.